Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024.
Several doses of semaglutide, the active ingredient in Wegovy and Ozempic, have been on the FDA's shortage list since early 2022.
In a statement, Novo Nordisk said all doses of Wegovy and Ozempic are being shipped regularly to wholesalers.
Still, Novo Nordisk said patients may not always be able to immediately fill their prescriptions at a particular pharmacy, even when a medication is listed as available.
"Our intentional approach to gradually increase supply into the U.S. market is working," Novo Nordisk said.
Persons:
Danish drugmaker, Eli Lilly, compounders
Organizations:
Novo Nordisk, U.S . Food, Nordisk, FDA
Locations:
Mitte, Germany, U.S, Danish, Novo